Literature DB >> 21167922

Universal wet-milling technique to prepare oral nanosuspension focused on discovery and preclinical animal studies - Development of particle design method.

Toshiyuki Niwa1, Satoru Miura, Kazumi Danjo.   

Abstract

Simple and easy methods to prepare oral nanosuspension of a poorly water-soluble pharmaceutical candidate compound, called a candidate, have been developed to support the discovery and preclinical studies using animals. The different wet-milling processes in miniature, middle and large preparation scales have been established in order to cover the various types of studies with wide scale. The powder of phenytoin, a poorly water-soluble model drug candidate, was suspended in the aqueous medium, in which the appropriate dispersing agents were dissolved, and milled by agitating together with small hard beads made of zirconia. Three general-purpose equipments with stirring, oscillating and turbulent motions were applied instead of the specific milling machine with high power to avoid much investment at such early development stage. The operational condition and dispersing agents were optimized to obtain finer particles using the middle-scaled oscillating beads-milling apparatus in particular. It was found that the nanosuspension, which whole particle distribution was in the submicron range, was successfully produced within the running time around 10min. By applying the newly developed dispersing medium, the nanoparticles with identical size distribution were also prepared using the stirring and turbulent methods on miniature and large scales, respectively; indicating only 50mg to 30g or more amount of candidate could be milled to nanosuspension using three equipments. The crystalline analysis indicated that the both crystal form and crystallinity of the original bulk drug completely remained after wet-milling process. The results demonstrated that the wet-milling methods developed in this research would be a fundamental technique to produce nanosuspension for poorly water-soluble and oral absorbable drug candidates. Copyright Â
© 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21167922     DOI: 10.1016/j.ijpharm.2010.12.013

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  15 in total

1.  Design of dry nanosuspension with highly spontaneous dispersible characteristics to develop solubilized formulation for poorly water-soluble drugs.

Authors:  Toshiyuki Niwa; Satoru Miura; Kazumi Danjo
Journal:  Pharm Res       Date:  2011-05-28       Impact factor: 4.200

2.  NanoClusters surface area allows nanoparticle dissolution with microparticle properties.

Authors:  Christopher Kuehl; Nashwa El-Gendy; Cory Berkland
Journal:  J Pharm Sci       Date:  2014-04-30       Impact factor: 3.534

3.  Comparative manufacture and cell-based delivery of antiretroviral nanoformulations.

Authors:  Shantanu Balkundi; Ari S Nowacek; Ram S Veerubhotla; Han Chen; Andrea Martinez-Skinner; Upal Roy; R Lee Mosley; Georgette Kanmogne; Xinming Liu; Alexander V Kabanov; Tatiana Bronich; JoEllyn McMillan; Howard E Gendelman
Journal:  Int J Nanomedicine       Date:  2011-12-20

4.  Evaluation of nanodispersion of iron oxides using various polymers.

Authors:  Y Tanaka; H Ueyama; M Ogata; T Daikoku; M Morimoto; A Kitagawa; Y Imajo; T Tahara; M Inkyo; N Yamaguchi; S Nagata
Journal:  Indian J Pharm Sci       Date:  2014-01       Impact factor: 0.975

5.  Controlled Suspensions Enable Rapid Determinations of Intrinsic Dissolution Rate and Apparent Solubility of Poorly Water-Soluble Compounds.

Authors:  Sara B E Andersson; Caroline Alvebratt; Christel A S Bergström
Journal:  Pharm Res       Date:  2017-06-15       Impact factor: 4.200

Review 6.  Nanocrystals of Poorly Soluble Drugs: Drug Bioavailability and Physicochemical Stability.

Authors:  Maria Rosa Gigliobianco; Cristina Casadidio; Roberta Censi; Piera Di Martino
Journal:  Pharmaceutics       Date:  2018-08-21       Impact factor: 6.321

Review 7.  Can formulation and drug delivery reduce attrition during drug discovery and development-review of feasibility, benefits and challenges.

Authors:  S Basavaraj; Guru V Betageri
Journal:  Acta Pharm Sin B       Date:  2014-01-24       Impact factor: 11.413

8.  Dissolution rate enhancement of clarithromycin using ternary ground mixtures: nanocrystal formation.

Authors:  Malihe Shahbaziniaz; Seyed Mohsen Foroutan; Noushin Bolourchian
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

Review 9.  Drug nanocrystals: A way toward scale-up.

Authors:  Kale Mohana Raghava Srivalli; Brahmeshwar Mishra
Journal:  Saudi Pharm J       Date:  2014-05-09       Impact factor: 4.330

Review 10.  Emerging role of nanosuspensions in drug delivery systems.

Authors:  Shery Jacob; Anroop B Nair; Jigar Shah
Journal:  Biomater Res       Date:  2020-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.